CD44 and breast carcinoma: Moreover, Li et al. have shown that an oncolytic herpes simplex virus deleted of γ34.5 could potently kill the CD44+CD24−/low population isolated from human breast cancer cell line SKBR-3 as well as primary human breast cancer cells [56].